C

Cyclacel Pharmaceuticals (CYCC)

$000.00 0.00% ($0.00)

Today
Week
Month
Year
5 Year
YTD

baraka

getbaraka.com

About Cyclacel Pharmaceuticals (CYCC)

Cyclacel Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing cancer medicines based on cell cycle, transcriptional regulation and mitosis control biology. The transcriptional regulation program is... Read more

Open
USD2.03
High
USD2.05
Low
USD1.90
52 Week High
USD49.34
Monthly Return
-42.20%
Revenue
0M

Daily Vol.
159.01k
Avg. Daily Vol.
462.11k
Market Cap.
45M
52 Week Low
1.95
Annual Return
-94.70%

Stock News

Why corporate bonds may be ‘fairly guarded’ from Moody’s downgrade of U.S. debt

Why corporate bonds may be ‘fairly guarded’ from Moody’s downgrade of U.S. debt

MarketWatch

Jim Cramer tells investors to tame their market fears

Jim Cramer tells investors to tame their market fears

CNBC

ASP Isotopes Inc. enters into Definitive Agreements with TerraPower including Loan Agreement for Construction of a HALEU Production Facility and Supply Agreements for HALEU

ASP Isotopes Inc. enters into Definitive Agreements with TerraPower including Loan Agreement for Construction of a HALEU Production Facility and Supply Agreements for HALEU

Yahoo

USTA to invest $800 million in US Open facilities in New York

USTA to invest $800 million in US Open facilities in New York

CNBC

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.

Build Your Long Term Wealth

Build Your Long Term Wealth

A modern investment app with fair pricing.

Top Movers

This list tracks the stocks with the most upwards (top gainers) and downwards (top losers) movement in price from the previous day.

Not sure which stock to invest in?

Not sure which stock to invest in?

Get access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.